Glaeser, J.D.; Ju, D.; Tawackoli, W.; Yang, J.H.; Salehi, K.; Stefanovic, T.; Kanim, L.E.A.; Avalos, P.; Kaneda, G.; Stephan, S.;
et al. Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats. Int. J. Mol. Sci. 2020, 21, 9709.
https://doi.org/10.3390/ijms21249709
AMA Style
Glaeser JD, Ju D, Tawackoli W, Yang JH, Salehi K, Stefanovic T, Kanim LEA, Avalos P, Kaneda G, Stephan S,
et al. Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats. International Journal of Molecular Sciences. 2020; 21(24):9709.
https://doi.org/10.3390/ijms21249709
Chicago/Turabian Style
Glaeser, Juliane D., Derek Ju, Wafa Tawackoli, Jae H. Yang, Khosrowdad Salehi, Tina Stefanovic, Linda E. A. Kanim, Pablo Avalos, Giselle Kaneda, Stephen Stephan,
and et al. 2020. "Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats" International Journal of Molecular Sciences 21, no. 24: 9709.
https://doi.org/10.3390/ijms21249709
APA Style
Glaeser, J. D., Ju, D., Tawackoli, W., Yang, J. H., Salehi, K., Stefanovic, T., Kanim, L. E. A., Avalos, P., Kaneda, G., Stephan, S., Metzger, M. F., Bae, H. W., & Sheyn, D.
(2020). Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats. International Journal of Molecular Sciences, 21(24), 9709.
https://doi.org/10.3390/ijms21249709
